EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer

Felix Blanc-Durand iD, Etienne Rouleau iD, Patricia Pautier iD, Natalie Ngoi iD, Yi Wan Lim iD, Siew Eng Lim iD, Alexandra Leary iD, David Sp Tan iD

Journal of Gynecologic Oncology · 2026

DOI: 10.3802/jgo.2026.37.e10 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Felix Blanc-Durand und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Department, Gynaecology Unit, Institut Gustave Roussy, Villejuif, France. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Loss of Heterozygosity. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National University of Singapore President's Graduate Fellowship, National Medical Research Council Singapore Clinician Scientist Award Senior Investigator Grant, Pangestu Family Foundation Gynaecological Cancer Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Genomic instability has been identified in a subgroup of endometrial cancers (ECs) that are predominantly TP53 mutated (TP53mut). We report the features associated with loss-of-heterozygosity (LOH) in EC. METHODS: We conducted a retrospective analysis of EC patients from France and Singapore. All patients underwent comprehensive molecular profiling using the tumor based FoundationOne CDX panel. The degree of LOH was correlated with molecular and clinicopathologic findings. LOH-high, intermediate and low were defined as ≥14%, 4%-14%, and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsLoss of HeterozygosityHumansFemaleMiddle AgedRetrospective StudiesAgedTumor Suppressor Protein p53Aged, 80 and overAdultMicrosatellite InstabilitySingaporeFranceMutationCarcinoma, EndometrioidReceptors, EstrogenReceptors, Progesterone

Stichwörter der Autor:innen

Endometrial CancerGenomic InstabilityHomologous Recombination DeficiencyPersonalized TreatmentPredictive Biomarkers

Substanzen

Tumor Suppressor Protein p53TP53 protein, humanReceptors, EstrogenReceptors, Progesterone

Autor:innen und Institutionen

  • Medical Oncology Department, Gynaecology Unit, Institut Gustave Roussy, Villejuif, France.
  • Department of Haematology-Oncology, National University Cancer Institute, Singapore.
  • Cancer Genetics Unit, Institut Gustave Roussy, Villejuif, France.
  • Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
  • National University Centre for Cancer Research (N2CR) and Cancer Science Institute (CSI) of Singapore, National University of Singapore, Singapore. david_sp_tan@nuhs.edu.sg.

ORCID-Profile: Felix Blanc-Durand, Etienne Rouleau, Patricia Pautier, Natalie Ngoi, Yi Wan Lim, Siew Eng Lim, Alexandra Leary, David Sp Tan

Förderung

  • National University of Singapore President's Graduate Fellowship
  • National Medical Research Council Singapore Clinician Scientist Award Senior Investigator Grant
  • Pangestu Family Foundation Gynaecological Cancer Research Fund
  • Shining Tower Foundation Medicine Grant
  • National University of Singapore President’s Graduate Fellowship

Zitieren

APA

Blanc-Durand, F., Rouleau, E., Pautier, P., Ngoi, N., Lim, Y. W., Lim, S. E., Leary, A., & Tan, D. S. (2026). Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e10

Vancouver

Blanc-Durand F, Rouleau E, Pautier P, Ngoi N, Lim YW, Lim SE, et al. Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e10

BibTeX
@article{BlancDurand2026,
  author = {Blanc-Durand, Felix and Rouleau, Etienne and Pautier, Patricia and Ngoi, Natalie and Lim, Yi Wan and Lim, Siew Eng and Leary, Alexandra and Tan, David Sp},
  title = {Clinical and biological characteristics associated with loss-of-heterozygosity in endometrial cancer},
  journal = {Journal of Gynecologic Oncology},
  year = {2026},
  doi = {10.3802/jgo.2026.37.e10}
}
Kostenlos starten →